← Leaderboards
Matthew A Ingersoll
Creighton University
$121,047
Attributed
$121,047
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $66.4K · FY2021–23$100K$75K$50K$25K$0
'21
'22
'23
Funding mix
By agency
NIH$121,047 · 1
By mechanism
F32$121,047 · 1
Top collaborators
No co-investigators on record.
Most similar at Creighton University
Same institution · by research overlap
- Tal Teitz$2,542,267
- Bernd Fritzsch$4,779,338
- Jonathan Paul Fleegel$128,617
- Justine Marie Renauld$642,073
- Kimberly A. Galt$1,978,602
Others in their field
Other Emerging Leaders on “Cochlea”
- Elaine Larkie Horn-Ranney · Tympanogen, Llc$4,715,143
- Artur Indzhykulian · Massachusetts Eye And Ear Infirmary$4,526,977
- Stãphane F. Maison · Massachusetts Eye And Ear Infirmary$4,488,340
- Basile Robin Tarchini · Jackson Laboratory$4,372,517
- Nicolas Grillet · Stanford University$4,309,975
- Lavinia Sheets · Washington University$3,351,432
Research focus
CochleaAlternative TreatmentAnti-CancerAdultAuditoryAuditory Brainstem ResponsesAwardBloodAntineoplastic AgentsAffectBraf GeneCancer TherapyCareerCell LineCell PhysiologyCellsCenters Of Research ExcellenceChemotherapeutic AgentChemotherapyCisplatinCisplatin Induced Hearing LossClinically RelevantClinical TrialsCore Facility